IGMS igmbio.com Return on Gross Profit

Official company branding of igmbio.com (IGMS)

IGM Biosciences, Inc. (IGMS) is mitigating risks through partnerships with pharma giants and a diverse range of clinical phases, although profitability depends on the integration of IgM antibodies into oncology center insurance systems. The operating gross margin demonstrates a balance between yield peaks and the threat of correction, where the 94.90 metric determines this level. Patent protection and a focus on bispecific drugs for autoimmune pathologies allow the company to optimize R&D costs.

IGMS (IGM Biosciences Inc.) Gross Margin history from 07/04/2022 to 08/24/2025

Analytical breakdowns and data insights for company igmbio.com (IGMS)

- market price and analyst price targets:
Basic company analysis:IGMS - IGM Biosciences, Inc.
Mass-produced product of IGM Biosciences, Inc.

The strategic alliance of IGM Biosciences, Inc. (IGMS) with an immunology pharma behemoth allows for the optimization of antibody development costs. By analyzing the company's gross profit margin, an investor determines the portion of revenue free from direct production costs, which is critical for assessing operational efficiency. Steady growth in this metric confirms the high added value of the technologies and the business model's resilience to price shocks.

Direct competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin JBIO|Return on Gross Profit aclaristx.com ACRS|Gross Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Gross Profit Margin|Cabaletta Bio, Inc - Gross Margin|Gross Profit Margin Ventyx Biosciences|THTX (theratech.com) - Return on Gross Profit|Return on Gross Profit Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Gross Margin|Gross Profit Margin Agenus Inc. AGEN|Return on Gross Profit CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Gross Profit Rate|Gross Profitability atyrpharma.com ATYR|Gross Margin Adagene Corp ADAG|IMA - Gross Profitability|Gross Profit Rate STTK (Shattuck Labs)|EQ: Gross Margin|Connect Biopharma (CNTB) - Gross Margin|Gross Profitability Immunic|Gross Margin atarabio.com|Gross Margin IFRX|Gross Margin X4 Pharma (XFOR)|Gross Margin ACET (adicetbio.com)|Gross Margin Celularity Inc. CELU|INMB - Gross Profitability|Gross Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Return on Gross Profit|Return on Gross Profit SAB Biotherapeutics Inc.|Return on Gross Profit AKTX|Return on Gross Profit enlivex.com (ENLV)|Gross Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Gross Sales Margin|Gross Margin EDSA (Edesa Biotech Corp)|Return on Sales by Gross Profit iBio (IBIO)|CARM - Gross Profitability|XTL Biopharmaceuticals (XTLB) - Return on Gross Profit|BOLT: Gross Margin|Return on Gross Profit HCW Biologics Inc.|Gross Profitability Aptevo|Gross Return on Sales AIM (AIM ImmunoTech, Inc.)|Gross Margin ADTX|Return on Sales by Gross Profit GRI Bio Corp|Gross Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Gross Profit Margin|Revelation Biosciences Corp - Gross Margin|INDP (Indaptus Therapeutics, Inc.) - Gross Return on Sales|SCNI: Gross Margin|CALI - Return on Sales by Gross Profit|AFMD (Affimed N.V.) - Gross Margin|Gross Profitability ALLK|Return on Gross Profit HOOK (HOOKIPA Pharma, Inc.)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability